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Tissue EngineeringReplication of Bone Marrow Differentiation Niche: 
Comparative Evaluation of Different Three-Dimensional 
Matrices
 Meghan J.  Cuddihy ,  Yichun  Wang ,  Charles  Machi ,  Joong Hwan  Bahng , 
 and  Nicholas A.  Kotov * 08 The interactions between hematopoietic stem cells (HSCs) 
and the bone marrow niche are very complex and poorly 
understood. [ 1 , 2 ] Bone marrow stroma, the tissue surrounding 
hematopoietic tissue, is composed of a variety of cell types 
and extracellular matrix (ECM) molecules. [ 3–7 ] HSCs interact 
with these cell types directly through cell–cell contacts or 
indirectly through secreted growth factors or ECM. Blood 
and bone marrow diseases, such as chronic myelogenous 
leukemia, acute myelogenous leukemia, and bone marrow 
failure syndromes, are characterized by disordered devel-
opment or production of hematopoietic cells in the bone 
marrow. [ 8 , 9 ] In fact, some of these HSC diseases are thought 
to be infl uenced by interactions with stromal cells. [ 10 ] Explo-
ration of the interactions between HSCs, surrounding stromal 
cells, and ECM is necessary for better understanding of these 
diseases. 
 Traditional in-vitro models of the HSC niche are 
dependent on HSC culture on 2D surfaces. In order to provide 
niche signals to the HSCs, they are cultured either on stromal 
cells, [ 11 , 12 ] in media supplemented with high concentrations of 
growth factors, [ 13 , 14 ] or both. Although the 2D models allow 
for the maintenance and expansion of HSCs, they lack the 
dimensionality and ECM components of the HSC niche. [ 15 ] 
With this in mind, 3D models of the bone marrow niche, 
primarily designed for HSC expansion, were developed. wileyonlinelibrary.com © 2013 Wiley-VCH V
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free co-cultures [ 17 ] to nanofi ber scaffolds [ 18 , 19 ] and synthetic 
polymers. [ 20–22 ] Most recently, De Barros et al. [ 17 ] developed 
a complex mixed multicellular spheroid in vitro model with 
human BMSC undifferentiated or induced for one week into 
osteoblasts. Both types of BMSC self-assembled in a 3D sphe-
roid effectively contact with hematopoietic progenitor cells. 
Cook et al. [ 23 ] describe a novel high-throughput 3D coculture 
system where murine-derived HSC can be cocultured with 
mesenchymal stem/stromal cells in 3D ‘micromarrows’, which 
supported the expansion of approximately twice as many 
HSC candidates as the 2D controls. Leisten et al. proposed 
a collagen-based 3D model for hematopoietic stem and pro-
genitor cells with mesenchymal stem cells to recapitulate the 
main components of the bone marrow niche, and proved the 
collagen-based 3D model enabled progenitor cell expansion. 
 Although these matrices vary in features such as sizes of 
pore structures, material types and sources, no study has com-
pared matrix features in the context of HSC culture. A com-
parison of key cell culture formats would help researchers 
determine what features of these matrices are necessary for 
mimicking the HSC niche. This is especially important for 
mimicking the healthy or diseased HSC niche in the context 
of drug testing, where the impact of a treatment may involve 
not only the HSCs but their interaction with stromal cells or 
ECM molecules. Knowledge of cell culture matrices features 
with regard to the HSC niche will aid researchers in better 
understanding of the interactions that occur in the HSC 
niche, and thereby better treatment options could be devel-
oped for diseases associated with the niche. 
 In the studies described here, we aimed to compare sev-
eral matrices with distinct spatial features: Matrigel is an 
ECM-based nanofi brous cell-encapsulating gel; Puramatrix is 
a synthetic peptide-based nanofi brous cell-encapsulating gel; 
inverted colloidal crystal (ICC) scaffolds are synthetic poly-
meric hydrogels with a distinct structure that does not fully 
encapsulate cells; and well plates are 2D solid polystyrene 
surfaces that serve as controls compared to the 3D matrices. 
 Matrigel is composed of ECM proteins extracted from 
Engelbreth-Holm-Swarm mouse sarcomas. [ 24 , 26 ] The gel has 
an advantage of being liquid at 4 ° C and gelling at 37  ° C. 
With this property, Matrigel can be mixed with cells, proteins, 
or other desired culture components at the low temperature, erlag GmbH & Co. KGaA, Weinheim small 2013, 9, No. 7, 1008–1015
Replication of Bone Marrow Differentiation Nicheand it will polymerize into a gel after plating at room tem-
perature. Matrigel contains several growth factors, including 
TGF-beta, epidermal growth factor, and fi broblast growth 
factor, so it can be a source of soluble signals that may be 
useful for certain applications. [ 26–29 ] Since Matrigel is com-
posed of in-vivo sources, cells can digest and restructure the 
matrix. [ 30 ] This feature is useful for through-tissue migration 
studies, [ 31 ] but can be hindering in tissue engineering or mod-
eling applications where matrix digestion disrupts the 3D 
structure. As well, the murine source of Matrigel introduces 
the potential of viral contamination. 
 The second gel we examined was Puramatrix, which is a 
peptide gel that self-assembles when exposed to the electro-
lytes in cell culture media. [ 32 ] The gels promote cell attach-
ment, [ 33 ] and can be plated in concentrations ranging from 
0.1–1%. Both Matrigel and Puramatrix are nanofi brous gels, 
which can be used to create 3D cell cultures by encapsulating 
the cells. However, Puramatrix is fairly inert comparing to 
Matrigel, because Matrigel contains exogenous growth fac-
tors and a heterogeneous fi brous makeup, while Puramatrix 
is composed of a synthetic protein but no growth factors. 
These encapsulating gels could be advantageous to HSC cul-
ture in that they allow for intimate cell–ECM interaction; 
however, the cell–cell interaction could be limited due to 
encapsulation. 
 We also looked at a 3D hydrogel matrix that allows for 
cell attachment but is not an encapsulating gel. Recently, 
these matrices, called inverted colloidal crystal (ICC) scaf-
folds, were utilized to design a 3D bone marrow analog. [ 34 ] 
ICC scaffolds are hydrogel matrices with uniformly shaped 
spherical cavities arranged in a hexagonal array where each 
cavity is connected to twelve adjacent cavities. [ 35–42 ] In a 
recent study, [ 34 ] the bone marrow analog utilized a trans-
parent acrylamide hydrogel with 70% water content, coated 
with clay nanocomposite to allow for cell attachment and to 
mimic the mineralized surface of bone. CD34  +  cells, hemat-
opoietic progenitor cells, were expanded within scaffolds with 
the support of growth factors and bone marrow aspirates, 
and the CD34  +  cells were then differentiated into functioning 
B-cells. The results showed that the 3D interactions are nec-
essary for control of CD34  +  cell cultures and purposeful 
ex-vivo bone marrow engineering. The ICC scaffolds dem-
onstrated some intrinsic advantages with the stromal-CD34  +  
cell co-culture. The geometry of closely-packed spherical 
cavities provided 3D interactions between the stromal cells 
and stem cells. Physically, the stem cells could contact stromal 
cells from multiple directions, especially when compared to 
the unidirectional interactions on 2D well plates. As well, sol-
uble factors are released in all directions from the attached 
stromal cells, eliminating the steep concentration gradient 
that is seen in 2D. The interconnectivity also played a big 
role in stromal-stem cell interactions. As CD34  +  cells are not 
attachment-based, they were free to migrate throughout the 
scaffold. This is unique to the ICC scaffolds when compared 
to encapsulation-based 3D matrices such as Matrigel. 
 We also performed parallel cultures in traditional 2D 
tissue cultured polystyrene. A direct comparison between 
these cell culture formats has not been performed sys-
tematically in the context of the HSC niche. In addition to © 2013 Wiley-VCH Verlag Gmbsmall 2013, 9, No. 7, 1008–1015dimensionality and feature scale, it is important to note the 
differences in cell–cell contacts in each of these formats. In 
2D culture, the as CD34  +  cells are plated on top of stromal 
cells so the two cell types are in direct contact. In order to 
provide a true 3D structure to the Matrigel and Puramatrix 
culture, one must encapsulate the cell cultures in the gel by 
mixing the gel and cells before plating. With cell encapsula-
tion, cells are surrounded and separated by matrix, limiting 
cell–cell contact. For cells to have cell–cell contact, they must 
digest the matrix and migrate to one another. As ICC scaf-
folds have a porous 3D structure, they can be seeded directly 
onto the matrix, allowing for them to contact not only the 
matrix but also each other. Thus, with these three matrices we 
can compare 2D and 3D matrices, as well as those with and 
without cell–cell contact. In vivo, bone marrow is a complex 
3D tissue with extensive cell–cell contacts. Replication of 
its essential functions in vitro inevitably forces the selection 
of only a subset of these interactions which determines the 
importance of a cell culture format. 
 In all culture formats, stromal-free cultures show a sparse 
number of CD34  +  cells and their progeny ( Figure  1 A,D,G). 
These cultures showed little, if any, expansion. All other 
images in Figure  1 feature cultures that included stromal 
cells. In 2D cultures (Figure  1 B,C) stromal cells lay fl at and 
CD34  +  cells and their progeny are smaller and remain round 
on top of the stromal cells. Stromal cells in Matrigel cultures 
(Figure  1 E,F) are rounded and isolated from the hemat-
opoietic cells due to encapsulation. Some stromal cells have 
migrated to the bottom of the plate and lay fl at (Figure  1 F). 
Puramatrix cultures showed similar morphologies. In ICC 
cultures, stromal cells are diffi cult to see because they con-
formably adhere to the matrix and the hematopoietic cells 
cluster within cavities. In all cultures, cells appeared mostly 
viable (Figure  1 J–L). 
 The number of cells that could be extracted from each 
culture type at days 7 and 14 were quantifi ed using a hema-
tocytometer ( Figure  2 A). These cells included both stromal 
cells, CD34  +  cells, and their progeny. In all matrices the num-
bers of cells in stromal cell-free culture were very low, indi-
cating that cells did not replicate. The cells extracted from 2D 
surfaces displayed little growth at day 7 but had expanded by 
day 14. Conversely, cells grown in Matrigel expanded signifi -
cantly at day 7 but had decreased by day 14. ICC scaffold cul-
tures displayed consistent cell numbers over the two weeks. 
The amount of expansion, represented as the number of cells 
extracted divided by the number of cells initially seeded in 
the cultures, is displayed in  Table  1 . 
 Enumeration of cells that were CD34  +  /lin  −  was performed 
by fl ow cytometry. In most matrices, stromal cell-free cultures 
displayed a higher percentage of cells that were CD34  +  /lin  −  
than cultures with stromal cells (Figure  2 B). It is important 
to remember that these cultures began with 100% CD34  +  /lin  −  
cells. In the majority of co-cultures, the percentage of CD34  +  /
lin  −  had decreased from 20% of the total number of cells (as 
seeded) to less than 10%. 
 The number of CD34  +  /lin  −  cells ( Figure  3 ) was calculated by 
multiplying the data shown in Figure  2 A by those in Figure  2 B. 
None of the matrices and cell combinations signifi cantly 
expanded the CD34  +  /lin  −  population (Table  1 ). 2D co-cultures 1009www.small-journal.comH & Co. KGaA, Weinheim
M. J. Cuddihy et al.
1010
communications
 Figure  1 .  Representative images of matrices. (A–I) Inverted microscope images (phase 
contrast) of cells in matrices on day 7. (J–L) Confocal images with live/dead stain. The fi rst 
row of images (A,B,C) shows cells grown in 2D, the second row (D,E,F) shows cells grown in 
Matrigel, and the third row (G,H,I) shows cells grown in ICC scaffolds. The fi rst column (A,D,G) 
displays CD34  +  cells grown alone, the second column (B,E,H) displays CD34  +  /hFOB 1.19 
co-cultures, the third column (C,F,I) displays CD34  +  /HS-5 co-cultures. The fourth row, cells 
stained with the live/dead assay, shows cells grown in (J) 2D, (K) Matrigel, and (L) ICCs. Green 
cells are alive, while cells stained red are dead. Images of Puramatrix cultures are not pictured 
because of their similarity to Matrigel cultures. Scale bar: (A–I) 100  μ m, (J–L) 80  μ m. displayed a recovery of the original number of CD34  +  /lin  −  cells 
between 7 and 14 days. ICC scaffolds displayed a fairly con-
sistent number of CD34  +  /lin1  −  cells from day 7 to day 14. 
Matrigel, in contrast to Figure  2 A, produced very few CD34  +  /
lin  −  cells by day 7, meaning that the expanded population 
seen in the fi rst seven days was a progeny population. Puram-
atrix showed low numbers of CD34  +  /lin  −  cells at day 7, but 
displayed a population profi le similar to Matrigel by day 14. 
 ELISAs for SCF, Flt-3, and IL-6 were performed on media 
extracted from cultures ( Figure  4 ). SCF and Flt-3 were found 
in concentrations much lower than levels used to expand 
HSCs. [ 18 ] IL-6 was found in concentrations 100 times higher 
than Flt-3 and IL-6. Stromal cell cultures had signifi cantly 
higher levels of IL-6 than cultures without stromal cells. In 
most cultures, HS-5 cells typically produced signifi cantly 
more IL-6 than hFOB 1.19 or stromal cell-free cultures. 
 We chose four cell culture formats with several different 
features to explore the contributions of dimensionality and 
cell–cell contacts in engineering an ex vivo HSC niche to www.small-journal.com © 2013 Wiley-VCH Verlag GmbH & Co. KGaAachieve eventually ex-vivo replica of bone 
marrow. The traditional 96-well plate was 
a 2D culture that allowed for communi-
cation through direct cell–cell interac-
tions and secreted cytokines, Matrigel and 
Puramatrix were 3D cultures where the 
matrix encapsulated the cells, allowing 
only for communication via secreted 
cytokines. ICC scaffolds represented 3D 
non-encapsulating cultures that allow for 
communication via direct contacts and 
secreted cytokines. 
 In addition to cell culture formats, we 
looked at several co-culture combina-
tions. All cultures were performed without 
cytokines, in order to reveal the effects of 
cell culture format and stromal cell type. 
As well, an ideal model of a HSC niche 
should have all signals provided by cells 
and matrix which should be the same as 
those provided by cells and ECM in vivo. 
A stromal-cell free culture served as a 
control. HS-5 cells were developed from 
bone marrow specifi cally for the support of 
HSCs. [ 11 , 12 ] HS-5 cells were shown to pro-
duce high levels ( > 1000 pg/mL) of growth 
factors IL-6, IL-8, granulocyte colony-
stimulating factor (G-CSF), and macro-
phage-inhibitory protein-1 alpha and also 
produced detectable levels of granulocyte-
macrophage-CSF (GM-CSF), macrophage-
CSF (M-CSF), Kit ligand (KL, also called 
SCF), and others. [ 11 ] Osteoblasts are impor-
tant to consider because (1) they secrete 
extracellular matrix and (2) they contribute 
to Ang1-Tie2 and transmembrane SCF 
signaling [ 7 , 44 , 48 ] taking place at osteoblast-
HSC contacts. The known cellular products 
of the hFOB 1.19 cell line include alkaline 
phosphatase and osteocalcin. [ 48 ]  The chosen matrices represented a diverse array of 
geometries (Figure  1 ). 2D cultures caused the stromal cells 
to lay fl at on the plate surface, and HSCs typically associated 
with the top of these cells. As CD34 + cells are not attachment-
based, the CD34  +  cells rarely contact the well plate, indicating 
that the CD34  +  cells showed affi nity towards cell–cell contacts. 
Matrigel and Puramatrix cultures began with cells encapsu-
lated through the matrix. After one week, it was observed 
that some stromal cells had migrated toward the bottom of 
the plate. ICC scaffolds allowed for direct 3D interactions 
between stromal cells and CD34  +  cells. It was observed that 
the CD34  +  cells and their progeny expanded in the cavities, 
forming small niches in several cavities. The geometry of the 
cavities where the stem cell expansion was observed (Figure 
 1 I and L) are very similar to the niches that are seen in actual 
bone marrow. [ 49–51 ] The geometry of ICC scaffolds is much 
like that of trabecular bone; thus, the directionality of inter-
actions and degree of contact between stromal and stem cells 
is very similar in ICCs and bone marrow. , Weinheim small 2013, 9, No. 7, 1008–1015
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 Figure  2 .  Number and phenotype of cells extracted from cultures. (A) Number of cells 
extracted from culture formats on indicated days. Note that all co-cultures produced 
signifi cantly (p < 0.05) more cells than the cultures with CD34  +  cells alone. In all instances, 
within the same matrix type and day, the number of cells produced by hFOB 1.19 co-cultures 
were not signifi cantly different when compared to the HS-5 cultures. (B) Percentage of cells 
that displayed the CD34  +  /lin  −  phenotype. For each matrix type, CD34  +  cells cultured alone 
displayed signifi cantly (p  < 0.05) higher percentages of CD34  +  /lin  −  cells than co-cultures of 
that same matrix type and day. (C) Representative dot plots of fl ow cytometry data for HS-5/
CD34  +  cultures in, from left to right, 2D, Matrigel, and ICC cultures at seven days. Percentages 
on dot plots indicate the percentange that measured CD34  +  /lin  −  .  2D co-cultures showed the largest expansion of CD34  +  /
lin  −  cells over 14 days (Figure  3 ); however, the total numbers 
of cells in these cultures are comparable to ICC and Matrigel 
cultures (Figure  2 ). This implies that 2D culture format specif-
ically promotes expansion of CD34  +  /lin  −  cells without further 
differentiation as can be detected by the chosen antibodies. 
ICC co-cultures, by comparison, show a more stable popula-
tion of CD34  +  /lin  −  cells, and total cells, over 14 days. 
 Matrigel cultures differentiated and expanded, or vice 
versa, over seven days. Interestingly, Puramatrix and Matrigel 
cultures have very similar numbers of CD34  +  /lin  −  cells at 
14 days for all co-cultures. The reason for the expansion and © 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheimsmall 2013, 9, No. 7, 1008–1015differentiation of HSCs in Matrigel may 
be due to the exogenous growth factors 
present in the matrix. As these factors 
were not replaced during media changes, 
the factors were likely used up during the 
culture, allowing for a recovery of CD34  +  /
lin  −  cell numbers during the second week 
for HS-5 cultures. Shown in Figure  4 C, 
HS-5 cultures secrete high levels of IL-6. 
As Matrigel and Puramatrix cultures iso-
late cells from one another due to matrix 
encapsulation, it is logical that the CD34  +  /
lin  −  growth profi les would follow the pro-
fi le of secreted factors. 
 We looked into three of the signals 
that were secreted in the media (Figure  4 ), 
and found that IL-6 was secreted at physi-
ologically relevant levels, particularly by 
HS-5 cells. Furthermore, we found that the 
pattern of IL-6 secretion in Figure  4 C fol-
lowed the pattern of CD34  +  /lin  −  cell num-
bers in Figure  3 . Thus, with the cell types 
used here, particularly HS-5, IL-6 is the 
secreted signal dominating CD34  +  /lin  −  cell 
maintenance. It is interesting to note that 
although all three formats presented sim-
ilar levels of IL-6, the 2D format showed 
the greatest expansion of CD34  +  /lin  −  cells. 
In 2D, there is a distinct concentration gra-
dient from the source of soluble cytokines 
at the bottom of the plate to the top of the 
plate. Therefore, in 2D cultures the HSCs 
are exposed to very high concentrations 
of soluble cytokines. In 3D cultures, this 
gradient is lessened considerably due to 
the arrangement of stromal cells, and thus 
the secretion of soluble cytokines, in three 
dimensions. 
 For both Matrigel and Puramatrix cul-
tures, CD34  +  /lin  −  cells expand signifi cantly 
between 7 and 14 days only in HS-5 co-
cultures. In 2D and ICC cultures, hFOB 
1.19 and HS-5 co-cultures show similar 
numbers of CD34  +  /lin  −  cells. It has been 
hypothesized that the direct cell–cell con-
tacts at the endosteal surface are impor-
tant for stem cell maintenance, particularly between HSCs and osteoblasts. [ 1 , 7 , 42 ] As the osteoblast-HSC 
interaction is between two transmembrane proteins, Ang-1 
and Tie2, [ 44 ] it is logical that the cultures with direct cell–cell 
contact enable these interactions. Thus, when utilizing oste-
oblasts as a source of signal for CD34  +  /lin  −  cell maintenance 
within an in vitro HSC niche, one needs to utilize a matrix 
that allows for physical contact between cells. 
 In summary, the ability to organize key aspects of the HSC 
niche ex vivo will provide a tool for studying pathology and 
potential cures for many blood and bone marrow diseases, 
including chronic myelogenous leukemia and bone marrow 
failure diseases. Critical evaluation of the best method to 1011www.small-journal.com
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 Table  1.  Expansion of cells in different matrices. 
  Total cells CD34  +  /lin  −  cells
 Day 7  Day 14  Day 7  Day 14 
2D CD34  +  alone 0.419 0.025 0.138 0.008
hFOB 1.19/ CD34  +  0.994 8.567 0.237 0.848
HS-5/ CD34  +  1.019 6.229 0.378 1.050
ICCs CD34  +  alone 0.113 0.150 0.047 0.013
hFOB 1.19/ CD34  +  1.305 0.660 0.425 0.186
HS-5/ CD34  +  0.461 0.855 0.293 0.089
Matrigel CD34  +  alone 0.304 0.431 0.015 0.014
hFOB 1.19/ CD34  +  5.591 1.789 0.024 0.052
HS-5/ CD34  +  13.502 5.408 0.112 0.504
Puramatrix CD34  +  alone 0.023 0.023 0.001 0.002
hFOB 1.19/ CD34  +  0.109 0.251 0.003 0.112
HS-5/ CD34  +  0.110 0.064 0.006 0.504
 Expansion is calculated by the number of cells extracted divided by the number of cells added to the matrix at the beginning of culture (total cells or CD34  +  /lin  −  cells). recreate the HSCs using stromal cells and different types 
of 3D matrix is much needed to establish a pathway toward 
adequate patient-specifi c ex-vivo bone marrow analogs. 2D 
well plate cultures demonstrated the greatest expansion of 
CD34  +  /lin  −  cells. These cultures provided both direct cell–cell 
contacts and soluble cytokine communication. ICC scaffolds, 
3D cultures that permitted both direct HSC-stromal cell con-www.small-journal.com © 2013 Wiley-VCH V
 Figure  3 .  Number of CD34  +  /lin  −  cells extracted. For all matrices and
produced signifi cantly (p < 0.05) more CD34  +  /lin  −  cells than CD34  +  cells 
comparing co-cultures within culture formats, at seven days, hFOB 1.19
2D produced signifi cantly more (p  < 0.05) CD34  +  /lin cells than did H
in 2D and at 14 days, for hFOB 1.19/CD34  +  cultures in Matrigel and P
signifi cantly more CD34  +  /lin  −  cells than did HS-5/CD34  +  cultures in these 
culture formats, 2D and ICC co-cultures produced signifi cantly more CD
Matrigel and Puramatrix at seven days, and at 14 days 2D cultures prod
lin  −  cells than all 3D matrices. tacts and the release of soluble cytokines, caused quiescence 
of the CD34  +  /lin  −  cells, much like what is seen in in vivo 
bone marrow. Matrigel cell cultures encapsulating the cells 
into ECM-type of environment inhibited cell–cell contacts 
but allowed for communication through soluble cytokines. 
They exhibited a great population of differentiated cells that 
did not have the CD34  +  /lin  −  phenotype. This fact should be erlag GmbH & Co. KGaA, 
 times, co-cultures 
grown alone. When 
/CD34  +  cultures in 
S-5/CD34  +  cultures 
uramatrix produced 
formats. Comparing 
34  +  /lin  −  cells than 
uced more CD34  +  /attributed to the exogenous growth fac-
tors contained in the matrix. Puramatrix 
showed a number of CD34  +  /lin  −  cells sim-
ilar to Matrigel after 14 days. 
 As the quiescent cancer stem cells 
are not affected by typical chemotherapy 
drugs, the ability to keep HSCs quiescent 
in culture is essential for modeling both 
healthy and diseased marrow. Consid-
ering an in-vitro HSC niche for the testing 
of drugs, one should utilize a 3D culture 
format that provides direct cell–cell con-
tacts, which is essential in designing an 
 ex vivo HSC niche. In addition to the 
dimensionality of cell–cell contacts and 
soluble cytokine gradients, one must also 
remember that in 3D cultures, the gradi-
ents of drugs, as well as the ability of HSCs 
protected by stromal cells, are much closer 
to in vivo condition. 
 Further work needs to be done to elu-
cidate the necessary cell types that cause 
HSCs to behave as they do in vivo. Once 
this is achieved, the model should also be 
examined by utilizing diseased HSCs, to 
ensure that the model can be used as a 
disease model. This will give clues to the 
pathophysiology of many blood and bone 
marrow diseases. Weinheim small 2013, 9, No. 7, 1008–1015
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 Figure  4 .  Concentrations of relevant cytokines in the media as determined by ELISAs. (A) SCF 
(B) Flt-3, (C) IL-6. Starred values represent values that are statistically signifi cant (p < 0.05) 
when compared to the other stromal cell in that culture format (i.e., 2D, Matrigel, or ICC) for 
that day (n  = 4–6). Note that although diffi cult to visualize on the Figure 4C, the average 
concentration of IL-6 for CD34 + cells grown alone, with hFOB 1.19 cells, and with HS-5 cells, 
respectively, in Puramatrix are as follows. 7 days (pg/mL): 83.7  ± 57.7, 26.3  ± 11.3, and 
927.9  ± 192.5. 14 days (pg/mL): 47.0  ± 19.5, 31.0  ± 11.5, and 135.3  ± 37.7.  Experimental Section 
 ICC Fabrication : Colloidal crystals were prepared in a manner 
similar to those previously described. [ 43 ] One gram of soda lime 
beads with a diameter of 80  μ m (Thermo Scientifi c) were mixed 
with ethylene glycol (approximately 5 mL). Under constant soni-
cation, one drop of beads was added every 20 min to the top of 
the pipette that was inserted into a 4.5 mm diameter vial. Drops 
were added until the height of beads in the vial was approximately 
1 cm. Ethylene glycol was evaporated in a furnace at 165  ° C over-
night, and beads were annealed at 665  ° C for 3 h. Annealed col-
loidal crystals were cracked out of the vials. 
 Cationic hydrogels were infi ltrated and formed in the colloidal 
crystals as follows. An initiator solution was made by adding potas-© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheimsmall 2013, 9, No. 7, 1008–1015sium persulfate (KPS, Sigma) (0.1 g) to deoxy-
genated water (10 mL). Next, an acrylamide 
precursor solution was made by adding  N,N -
dimethylacrylamide (DMAA, Aldrich) (3.5 g), 
(3-Acrylamidopropyl)trimehtylammonium 
chloride (AMTAC, Aldrich) (0.5 g) and  N,N -
methylenebis(acrylamide) (MBA, Aldrich) 
(0.05 g) to deoxygenated water (9 mL). Col-
loidal crystals were added to vials, and enough 
precursor solution was added to completely 
submerge the crystals. The colloidal crystals 
were then centrifuged in precursor solution for 
25 min at 5500 RPM. Next, initiator (300  μ L) 
was added to each vial, and centrifugation 
was repeated for an additional 15 min. Vials 
were heated in an oven for 3h at 75  ° C with 
the caps placed on the vials but not screwed 
tight, and then overnight at 60  ° C with caps 
screwed tight. Gels were then cracked out of 
vials, and excess gel was scraped off of the 
colloidal crystals using a razor blade. 
 Glass beads were removed as described 
previously using a series of hydrofl uoric 
acid and hydrochloric acid washes; removal 
of soda lime was accelerated by ultrasoni-
cating during acid washes. The resultant 
1 cm ICCs were washed several times in phos-
phate buffered saline (PBS) before cutting. 
To cut the 1 cm ICCs into thin scaffolds, ICCs 
were fi rst mounted in HistoGel (Thermo Sci-
entifi c), and cut into 350  μ m thick sections 
using a Vibratome 3000 series sectioning 
system (VIbratome, St. Louis, MO). Thin ICCs 
were then washed sequentially with PBS, pH 
10 buffer, calcium chloride, and PBS. Scaf-
folds were sterilized by washing in 190 proof 
ethanol, and then were washed twice in sterile 
PBS. 
 Stromal Cell Expansion : Human fetal oste-
oblast (hFOB) cell line 1.19 (CRL-11372) and 
human bone marrow stromal (HS-5) cells 
(CRL-11882) were purchased from American 
Tissue Culture Corporation (ATCC, Manassas, 
VA) hFOB 1.19 cells were grown as recom-
mended by ATCC in 45% Ham’s F12 medium, 45% Dulbecco’s modifi ed Eagle’s Medium (DMEM), and 10% fetal 
bovine serum (FBS) (Gibco, Frederick, MD) supplemented with G418 
(0.3 mg/mL). HS-5 cells were grown as recommended by ATCC in 
DMEM supplemented by 10% FBS and 1% penicillin-streptomycin. 
Both cell types were grown at 37  ° C and 5% carbon dioxide (CO 2 ), 
with the medium changed every 2 to 3 days. 
 Stromal and CD34 + Seeding in 2D Cultures : For each matrix 
type, hFOB 1.19 or HS-5 cells were seeded at a density of 
40 000 cells per culture. This number was chosen to avoid con-
tact inhibition in 2D 96-well plate cultures. Stromal cells were 
seeded directly onto the plate, and allowed to attach for three 
hours before irradiating at 6000 rads with  γ -rays. Media was then 
changed to StemSpan (StemCell Technologies, Vancouver, BC) 
supplemented with 40  μ g/mL low density lipoprotein (Sigma) 1013www.small-journal.com
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and 1% penicillin-streptomycin. Frozen bone marrow CD34  +  cells 
(StemCell Technologies) were thawed and washed with StemSpan 
as directed by the cell supplier. CD34  +  cells were added to cell cul-
tures at a density of 10 000 cells/well and cultured at 37  ° C and 
5% CO 2 . Controls were prepared by culturing CD34 
 +  cells without 
stromal cells in 96-well plates. 
 Stromal and CD34 + Seeding in Matrigel Cultures : In order to 
co-culture stromal cells with CD34  +  cells in Matrigel, hFOB 1.19 
and HS-5 cells were  γ -irradiated at 6000 rads in 75 cm 2 fl asks prior 
to seeding in gels. Matrigel cultures were prepared according to 
manufacturer’s instructions for culturing cells within the matrix. 
Briefl y, three tubes were placed on ice and equal volumes of 
Matrigel was pipetted into each tube. hFOB 1.19 or HS-5 cells were 
counted and placed into Matrigel tubes so that each well would 
receive 40 000 stromal cells; the third tube was left without cells. 
CD34  +  cells were thawed and washed with StemSpan, and CD34  +  
cells were added to cell cultures at a density so that 10 000 CD34  +  
cells would be included in each well. Matrigel, stromal cells, and 
CD34  +  cells were gently mixed by pipetting, and 32  μ L of Matrigel-
cell mixtures were added to each well. Cells were cultured at 37  ° C 
and 5%CO 2 . 
 Stromal and CD34 + Seeding in Puramatrix Cultures : As with 
Matrigel cultures, hFOB 1.19 and HS-5 cells were irradiated at 
6000 rads in 75 cm 2 fl asks prior to seeding in Puramatrix gels. 
Puramatrix cultures were prepared according to manufacturer’s 
instructions for encapsulating cells. Briefl y, Puramatrix (25  μ L) 
was added to each well with an equal volume of cell suspension. 
Cell suspensions were prepared in concentrations described for 
Matrigel cultures, except cells were suspended in 10% sucrose 
solution instead of media. Suspensions were mixed with Purama-
trix directly in the well plate, and cultures were allowed to set for 
5 minutes before StemSpan media was layed on top. Media was 
changed twice over the next hour. Cells were cultured at 37  ° C and 
5% CO 2 . 
 Cell Seeding in ICC Scaffolds : One scaffold was placed in a 
well of a 96-well plate. 100  μ L of 190 proof ethanol was added to 
each well. Scaffolds were allowed to equilibrate for 10 min before 
ethanol was removed and replaced with an additional fresh eth-
anol (100  μ L). After 10 min, most of the ethanol was removed and 
plates were placed in an incubator at 37  ° C overnight to evapo-
rate any residual ethanol. The next day, cell solutions of either 
hFOB 1.19 or HS-5 cells were made at a density of 40 000 cells 
per 20  μ L. 20  μ L of cell suspension gently was pipetted directly 
onto each dehydrated scaffold, and well plates were placed in an 
incubator for three hours. Wells were then fi lled halfway with HS-5 
media (described above), and cells and scaffolds were irradiated 
at 6000 rads. Media was then removed and replaced with Stem-
Span media. CD34  +  cells were thawed and washed with StemSpan 
as described above. CD34  +  cells were added to cell cultures at a 
density of 10,000 cells/well and cultured at 37  ° C and 5%CO 2 . 
Controls were prepared by culturing CD34  +  cells without stromal 
cells in ICC scaffolds. 
 Live/Dead Staining : After 8 days of culture, cells were incu-
bated in calcein AM (2 mM) and ethidium homodimer-1 (4 mM) 
using a Live/Dead Viability/Cytotoxicity Kit (Invitrogen Corpora-
tion, Carlsbad, CA). Images were acquired directly in 96-well plates 
using a Leica DM IRB inverted microscope. 
 Flow Cytometric Analysis : Enumeration of cells expressing 
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